British private equity firm Grovepoint Capital has acquired control of biotechnology company Algatechnologies Ltd. at a value of $50 million. Founded by Kibbutz Ketura in 1998, Algatechnologies commercially cultivates the microalgae Haematococcus pluvialis to supply a powerful antioxidant – astaxanthin.
Algatechnologies was founded on the basis of research by Prof. Sammy Boussiba at Ben Gurion University of the Negev Landau Family Microalgal Biotechnology Laboratory, and the company is run by chairman Ed Hofland and CEO Hagay Tzur. The company’s shareholders are Kibbutz Ketura and the Jewish Colonization Association.
…Full text: www.globes.co.il/serveen/globes/docview.asp?did=1000820990&fid=1725
Tags: AstaPure, pharmaceuticals, Israel, microalgae-based biological substances, agriculture, food , water, energy, cleantech
Source
Globes, 2013-02-10.
Supplier
Algatechnologies Ltd.
Ben-Gurion University of the Negev
Grovepoint Capital
Share
Renewable Carbon News – Daily Newsletter
Subscribe to our daily email newsletter – the world's leading newsletter on renewable materials and chemicals